Effectiveness of a multidrug therapy consisting of Ivermectin, Azithromycin, Montelukast, and Acetylsalicylic acid to prevent hospitalization and death among ambulatory COVID-19 cases in Tlaxcala, Mexico

OBJECTIVE: There is an urgent need for effective treatments to prevent or attenuate lung and systemic inflammation, endotheliitis, and thrombosis related to COVID-19. This study aimed to assess the effectiveness of a multidrug-therapy consisting of Ivermectin, Azithromycin, Montelukast, and Acetylsa...

Descripción completa

Detalles Bibliográficos
Autores principales: Lima-Morales, René, Méndez-Hernández, Pablo, Flores, Yvonne N., Osorno-Romero, Patricia, Sancho-Hernández, Christian Ronal, Cuecuecha-Rugerio, Elizabeth, Nava-Zamora, Adrián, Hernández-Galdamez, Diego Rolando, Romo-Dueñas, Daniela Karola, Salmerón, Jorge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872854/
https://www.ncbi.nlm.nih.gov/pubmed/33578014
http://dx.doi.org/10.1016/j.ijid.2021.02.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872854/
https://www.ncbi.nlm.nih.gov/pubmed/33578014
http://dx.doi.org/10.1016/j.ijid.2021.02.014

Ejemplares similares